Results 11 to 20 of about 4,701 (210)

T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. [PDF]

PLoS ONE, 2010
BACKGROUND: Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of childhood mortality worldwide. Two types of pertussis vaccines are currently available, whole-cell, and the more recent acellular vaccines ...
Pascal Feunou Feunou, Julie Bertout, Camille Locht   +2 more
doaj   +4 more sources

Outer Membrane Vesicles as a Versatile Platform for Vaccine Development: Engineering Strategies, Applications and Challenges. [PDF]

J Extracell Vesicles
ABSTRACT Outer membrane vesicles (OMVs) are nanosized vesicles naturally secreted by Gram‐negative bacteria and represent a promising platform for vaccine development. OMVs possess inherent immunostimulatory properties due to the presence of pathogen‐associated molecular patterns (PAMPs), providing self‐adjuvanting capabilities and the ability to ...
Garling A, Auvray F, Epardaud M, Oswald É, Branchu P.   +4 more
europepmc   +2 more sources

The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae [PDF]

Journal of Bacteriology, 2008
Gross R, Guzman CA, Sebaihia M, et al. The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae. BMC Genomics. 2008;9(1): 449.Background: Bordetella petrii
Alexander Goesmann, Alfred Pühler, Amit N Khachane, Burkhard Linke, Carlos A Guzman, Christian Rückert, Christof Larisch, Daniela Bartels, Diana Nakunst, Dietmar H Pieper, Folker Meyer, Frank-Jörg Vorhölter, Helmut Blöcker, Jacquelyn T Engle, Jens Buhrmester, Jomuna V Choudhuri, Kai Schulze, Lars Gaigalat, Melanie Lechner, Mohammed Sebaihia, Olaf Kaiser, Ralf Koebnik, Rosa Martinez-Arias, Roy Gross, Sascha Mormann, Stefanie Herrmann, Stefanie Link, Susanne Schneiker-Bekel, Tetyana Yevsa, Thomas Ebensen, Ulf B Göbel, Vítor AP Martins dos Santos, William E Goldman   +32 more
core   +10 more sources

RETRACTED: Melanin Produced by Bordetella parapertussis Confers a Survival Advantage to the Bacterium during Host Infection

mSphere, 2021
Bordetella parapertussis causes respiratory infection in humans, with a mild pertussis (whooping cough)-like disease. The organism produces a brown pigment, the nature and biological significance of which have not been elucidated.
Yukihiro Hiramatsu, Takashi Nishida, Dendi Krisna Nugraha, Fuminori Sugihara, Yasuhiko Horiguchi   +4 more
doaj   +1 more source

Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis [PDF]

Journal of Medical Microbiology, 1991
The viability of four strains of Bordetella bronchiseptica, two strains of B. pertussis and one strain of B. parapertussis exposed to hyperimmune and pre-colostrum porcine serum was examined. Viable cell numbers (cfu/ml) of the B. pertussis strains and a rough strain of B.
D W, Byrd, R M, Roop, H P, Veit, G G, Schurig   +3 more
openaire   +2 more sources

Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms. [PDF]

PLoS ONE, 2017
B. parapertussis is a whooping cough etiological agent with the ability to evade the immune response induced by pertussis vaccines. We previously demonstrated that in the absence of opsonic antibodies B.
Juan Gorgojo, Emilia Scharrig, Ricardo M Gómez, Eric T Harvill, Maria Eugenia Rodríguez   +4 more
doaj   +1 more source

Bordetella pertussis,B. parapertussis, vaccines and cycles of whooping cough [PDF]

Pathogens and Disease, 2015
Whooping cough is a vaccine-preventable disease due to Bordetella pertussis and B. parapertussis. This highly contagious respiratory disease occurs through epidemic cycles every 3-5 years and vaccination did not change this frequency. Models suggest that the cyclic increase of susceptibles is linked to demographic differences and different vaccine ...
Bouchez, Valérie, Guiso, Nicole
openaire   +3 more sources

Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B. parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis [PDF]

Clinical Diagnostic Laboratory Immunology, 2001
ABSTRACT Serum immunoglobulin G (IgG) antibodies against the lipooligosaccharide (LOS) of Bordetella pertussis and the lipopolysaccharide (LPS) of Bordetella parapertussis were measured by enzyme-linked immunosorbent assay in paired sera from 40 children with pertussis and 14 with ...
B, Trollfors, T, Lagergård, J, Taranger, E, Bergfors, R, Schneerson, J B, Robbins   +5 more
openaire   +2 more sources

Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussis. [PDF]

PLoS ONE, 2012
Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, a respiratory disease that is reemerging worldwide. Mechanisms of selective lymphocyte trafficking to the airways are likely to be critical in the immune response to this ...
Tuan M Nguyen, Dipti Ravindra, Brian Kwong, Sana Waheed, Ryan Ferguson, Nicole Tarlton, Victoria Wu, Christopher S Sequeira, Martina Bremer, Tzvia Abramson   +9 more
doaj   +1 more source

Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines [PDF]

Archives of Disease in Childhood, 2003
To investigate the clinical picture and frequency of Bordetella pertussis and B parapertussis infections after introduction of acellular pertussis (acP) vaccines in Germany.Prospective surveillance for B pertussis and B parapertussis in 14 144 toddlers. Pertussis vaccination coverage was 86%, either with acP (75%) or whole cell pertussis (wcP) vaccine (
J G, Liese, C, Renner, S, Stojanov, B H, Belohradsky   +3 more
openaire   +2 more sources